Mixed effects modeling of the disposition of gentamicin across domestic animal species

Journal of Veterinary Pharmacology and Therapeutics

Volumn 24, Issue 5, 2001, Pages 321-332

  Martin Jimenez T ^a   Riviere, J E ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN;

ANALYTIC METHOD; ANIMAL DISEASE; ARTICLE; BODY WEIGHT; BRAIN WEIGHT; CLINICAL FEATURE; CONTROLLED STUDY; DATA BASE; DISTRIBUTION VOLUME; DOMESTIC ANIMAL; DRUG CLEARANCE; DRUG DISTRIBUTION; NONHUMAN; POPULATION MODEL; PREDICTION; PRIORITY JOURNAL; SERUM; SPECIES DIFFERENCE; VALIDATION PROCESS;

ANIMALS; ANTI-BACTERIAL AGENTS; CATS; DATABASES, FACTUAL; DOGS; GENTAMICINS; GOATS; HALF-LIFE; HORSES; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; RABBITS; SHEEP; SPECIES SPECIFICITY; SWINE;

ANIMALIA; SUS SCROFA;

EID: 0034782276     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2001.00346.x     Document Type: Article

References (26)

1. Pharmacokinetics of gentamicin following single dose intravenous administration in normal and febrile goats
2. Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics
3. Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm
4. Mixed effect modeling of sumatriptan pharmacokinetics during drug development I: Interspecies allometric scaling
5. Gentamicin population pharmacokinetic models for low birth weight infants using a new nonparametric method
6. Comparison of population pharmacokinetic models for gentamicin in spinal cord-injured and able-bodied patients
7. The influence of endotoxin-induced pyrexia on the pharmacokinetics of gentamicin in the rabbit
8. Individualizing gentamicin dosage regimens: A comparative review of selected models, data fitting methods, and monitoring strategies
9. Pharmacokinetics of gentamicin in cats given E. coli endotoxin
10. Variation in plasma half-life of gentamicin between species in relation to body weight and taxonomy
11. Population pharmacokinetics of gentamicin. Use of the nonparametric expectation maximization (NPEM) algorithm
12. Population pharmacokinetics of gentamicin in horses
13. Population pharmacokinetics in veterinary medicine: Potential use for therapeutic drug monitoring and prediction of tissue residues
14. Population pharmacokinetic models and Bayesian forecasting applied to clinical pharmacokinetics
15. The food animal residue avoidance databank (FARAD)
16. Gentamicin sulfate pharmacokinetics: Lower levels of gentamicin in blood during fever
17. Aminoglycoside-induced toxic nephropathy
18. Species dependent gentamicin pharmacokinetics and nephrotoxicity in the young horse
19. Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species
20. Some suggestions for measuring predictive performance
21. Gentamicin pharmacoki-netics in horses given small doses of Escherichia coli endotoxin
22. Influence of endotoxin-induced fever on the pharmacokinetics of gentamicin in ewes
23. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations